Song‐Yang Wu

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Yi Xiao, Ding Ma, Yun‐Song Yang et al. · Cell Research · 2022 · 322 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +17

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Song‐Yang Wu, Ying Xu, Li Chen et al. · Molecular Cancer · 2022 · 97 citations · Full text

Life Sciences, Immunology, Oncology +17

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu et al. · Clinical Cancer Research · 2022 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer

Minhong Shen, Heath A. Smith, Yong Wei et al. · Nature Cancer · 2021 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +16

Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis

Minhong Shen, Yong Wei, Hahn Kim et al. · Nature Cancer · 2021 · 77 citations · Full text

Medicine, Oncology, Pharmacology +12